The trial will evaluate the safety and effectiveness of remdesivir, an antiviral drug that has been tested in humans with Ebola virus.
Recent Articles by
March 25, 2020
Boosted by a philanthropic gift, UVA Health hopes to soon be able to ramp up its testing capacity to more than 500 tests per day.
March 03, 2020
It’s March, and UVA is hoping to bust more than one bracket. An artificial pancreas system developed at UVA is part of STAT Madness, focused on the best biomedical research of 2019.
February 26, 2020
Teams of physicians, researchers and engineers at UVA, Virginia Tech and Carilion Clinic are collaborating on projects that could lead to treatment options for cancer and depression, among other ailments.
January 02, 2020
The breakthrough system combines a glucose sensor, insulin pump and a smart control algorithm to allow Type 1 diabetes patients to continually regulate blood-sugar levels.
October 28, 2019
The group is charged with making further recommendations to improve billing and collection policies and practices to better meet the needs of patients.
October 16, 2019
A new study, based at UVA and other centers, shows that the system developed at UVA’s Center for Diabetes Technology offers safety and efficacy benefits for people with Type 1 diabetes.
September 13, 2019
The UVA Medical Center revised its billing and collection practices, which will reduce bills for low-income and uninsured patients, and focus on workable repayment plans while relying less on the legal system to collect debts.
August 01, 2019
Collins is perhaps best known for serving as director of the National Human Genome Research Institute, where he led the international Human Genome Project.
July 30, 2019
In addition, the publication ranked nine UVA specialties among the top 10% nationally, including three that placed in the top 35.